Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| ARS Pharmaceuticals, Inc. | 875 000 | déclaré | 02 janv. 2026 | tx 107+20 919 127−4 510 285 |
| CADENCE PHARMACEUTICALS INC | 25 000 | déclaré | 22 mars 2007 | tx 1+25 000 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 02 janv. 2026 | GRANT_AWARD | ARS Pharmaceuticals, Inc. | 240 000 | 0.00 USD | deriv |
| 02 janv. 2026 | GRANT_AWARD | ARS Pharmaceuticals, Inc. | 875 000 | 0.00 USD | deriv |
| 21 août 2025 | SALE | ARS Pharmaceuticals, Inc. | 50 000 | 14.49 USD | |
| 02 janv. 2025 | GRANT_AWARD | ARS Pharmaceuticals, Inc. | 261 900 | 0.00 USD | deriv |
| 02 janv. 2025 | GRANT_AWARD | ARS Pharmaceuticals, Inc. | 767 600 | 0.00 USD | deriv |
| 17 déc. 2024 | SALE | ARS Pharmaceuticals, Inc. | 50 000 | 11.67 USD | |
| 17 déc. 2024 | SALE | ARS Pharmaceuticals, Inc. | 50 000 | 11.67 USD | |
| 10 déc. 2024 | SALE | ARS Pharmaceuticals, Inc. | 50 000 | 13.16 USD | |
| 10 déc. 2024 | SALE | ARS Pharmaceuticals, Inc. | 50 000 | 13.17 USD | |
| 06 déc. 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 11 876 | 8.42 USD | |
| 06 déc. 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 13 789 | 1.44 USD | |
| 06 déc. 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 11 876 | 8.42 USD | |
| 06 déc. 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 11 876 | 0.00 USD | deriv |
| 06 déc. 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 13 789 | 0.00 USD | deriv |
| 06 déc. 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 11 876 | 0.00 USD | deriv |
| 19 nov. 2024 | SALE | ARS Pharmaceuticals, Inc. | 50 000 | 13.95 USD | |
| 19 nov. 2024 | SALE | ARS Pharmaceuticals, Inc. | 50 000 | 13.95 USD | |
| 12 nov. 2024 | SALE | ARS Pharmaceuticals, Inc. | 45 045 | 16.76 USD | |
| 12 nov. 2024 | SALE | ARS Pharmaceuticals, Inc. | 4 955 | 17.64 USD | |
| 12 nov. 2024 | SALE | ARS Pharmaceuticals, Inc. | 45 124 | 16.76 USD | |
| 12 nov. 2024 | SALE | ARS Pharmaceuticals, Inc. | 4 876 | 17.64 USD | |
| 15 oct. 2024 | SALE | ARS Pharmaceuticals, Inc. | 1 450 | 15.25 USD | anomalie |
| 15 oct. 2024 | SALE | ARS Pharmaceuticals, Inc. | 50 000 | 14.88 USD | |
| 15 oct. 2024 | SALE | ARS Pharmaceuticals, Inc. | 48 550 | 14.86 USD | |
| 08 oct. 2024 | SALE | ARS Pharmaceuticals, Inc. | 50 000 | 13.83 USD |